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Nasopharyngeal neoplasms
AngiofibromaIntroduction: Juvenile nasopharyngeal angiofibroma (JNA) is a locally aggressive benign vascular tumour
exclusively amongst adolescence males. General characteristics, management and outcomes of 11 cases
of JNA presented to our centre between 2000 till 2015 were studied and evaluated.
Objective: This is a retrospective study to determine general characteristics, management and outcomes
amongst the local population of Kelantan, Malaysia.
Methods: 11 patients from the local population of Kelantan who presented between 2000 till 2015 were
evaluated respectively. Demographical data, clinical presentation, duration of symptoms, stage of disease,
surgical approach and outcomes of these 11 patients were reviewed and collected from the medical
record office at our centre.
Results: All 11 patients were Malay male with the average age at diagnosis being 15 years (range 11–21)
years. Among the local population, predominant clinical presentation includes nasal obstruction followed
by spontaneous painless epistaxis. All 11 patients were subjected to embolization prior to surgery.
Surgery was the first line treatment for all our patients. Our patients were mostly subjected to endoscopic
approach (37%) and combined approach (36%). Recurrence were seen in 5 patients (64%). 2 patients
underwent radiotherapy one of which was combined with chemotherapy due to intracranial involve-
ment. None of our patients sustained major intra- or post-operative complications.
Conclusions: Surgery combined with preoperative embolization is the main modality of treatment at our
centre. Based on our observation, patients delay and refusal of surgery, ineffective embolization have led
to recurrence. Timely diagnosis and management together with patients co-operation is critical for suc-
cessful outcome.
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nd/4.0/).1. Introduction
Juvenile nasopharyngeal angiofibroma (JNA) is a locally aggres-
sive benign vascular tumour exclusively amongst adolescence
males. It comprises of 0.5% of all head and neck tumours1 and is
the most common benign tumour of nasopharynx. This tumour is
said to originate from the superior aspect of the sphenopalatine
foramen which is formed by the sphenoidal process of palatine
bone and pterygoid process of the sphenoid bone. Age distribution
of this entity is between 14 and 25 years2 although several case has
been reported involving men over 25 years and even amongst
female.3Common clinical presentation includes: nasal obstruction, epis-
taxis and nasopharyngeal mass.4 JNA originates from the superior
margin of the sphenopalatine foramen and has a tendency to grow
and extend along the natural foramina and fissures associated with
its site of origin.
Genetic studies have demonstrated a close relation between
these angiomas and androgen receptor expression, suggesting that
this tumour is androgen-dependent. This could explain why the
prevalence is higher in males.5,6 Diagnosis is made based on a care-
ful clinical history and a detailed physical examination to describe
the signs and symptoms, the morphology and epidemiology, and
the radiological findings. Advent of imaging techniques have led
to major advances in the diagnosis and treatment of angiofibro-
mas. Nasal endoscopy, computed tomography, and magnetic
resonance imaging help establish the site and extension of this
tumour and the relations with blood vessels and nerves, all of
which make it possible to precisely stage the tumour. Biopsiesntre: A
2 J. Saniasiaya et al. / Egyptian Journal of Ear, Nose, Throat and Allied Sciences xxx (2016) xxx–xxxare not recommended because of the vascular and hemorrhagic
nature of this tumour. Arteriography is done to assess the vascular
supply in larger tumours and to make it possible to embolize these
vascular lesions to reduce intraoperative bleeding. Endoscopy
approach is the current cornerstone of management.
Albeit histologically benign, tumour is locally aggressive, high
persistence and recurrence.5 Recurrence has been reported to be
20–42% although it may be higher with intracranial extension. Sur-
gical resection is said to be the first line treatment in many centres
although other modalities of treatment including radiotherapy and
chemotherapy have been reported. As for the choice of surgical
approach, mostly it depends on the location of JNA, the extension
and surgeons experience. Types of surgical approach includes:
midfacial degloving, lateral rhinotomy, transpalatine and recently
endoscopic approach are widely used.
2. Methodology
This is a 15 years retrospective study fully conducted in Hospi-
tal Universiti Sains Malaysia amongst 11 patients. Patient’s case
notes from the 1st January 2000 till 31st December 2015 were col-
lected from the medical record office and were meticulously
reviewed and analysed.
Demographical data, clinical presentation, duration of symp-
toms, stage of disease, surgical approach and outcomes of these
11 patients were reviewed and collected from the medical record
office at our centre. The Fisch (Fisch, 1983)7 (Table 1) criteria were
applied to classify the tumours based on computer tomography
(CT) findings.
3. Results
A total of 11 patients were managed in our centre from the 1st
January 2000 till the 31st December 2015 who were referred from
various private and neighbouring government hospitals. All 11
patients were Malay male with the average age upon diagnosis
being 15 years (range 11–21 years).
Among the local population, predominant clinical presentation
includes unilateral spontaneous painless epistaxis (35%) followed
by unilateral nasal obstruction (34%), nasal discharge (19%), voice
changes (6%) and ocular symptoms and abnormal facial contour
seen amongst 3% each. Duration of symptoms till first presentation
were between 1 month to 24 months with a mean of 12 months
seen amongst our patients. Nasoendoscopic examination per-
formed for all our patients revealed vascular, lobulated mass in
the nasopharynx. Provisional diagnosis for all the 11 patients were
JNA hence, no biopsy was made.
Contract enhanced CT was performed for all our patients and
categorized based on Fisch staging. Our patients mostly resented
at Stage II (46%) upon diagnosis followed by Stage IV (27%), Stage
I (18%) and 9% seen in Stage III. There is no association seen
between duration of symptoms and staging in our centre (p value
is 0.588). All our patients were subjected to selective embolizationTable 1
Fisch staging.
Stage Description
I Tumours limited to nasal cavity, nasopharynx with no bony
destruction
II Tumours invading the pterygomaxillary fossa, paranasal sinuses with
bony destruction
III Tumours invading the infratemporal fossa, orbit and parasellar
region, remaining lateral to the cavernous sinus
IV Tumours with invasion to the cavernous sinus, optic chiasmal region
and pituitary fossa
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fifteen year experience. Egypt J Ear Nose Throat Allied Sci (2016), http://dx.doprior to surgery with a mean interval of 48–36 h with no complica-
tions documented. Surgery was the first line treatment for all 11
patients in our centre. As for the approach, our patients were
mostly subjected to transnasal endoscopy (37%) followed by com-
bined approach which includes a combination of two open
approaches (36%), lateral rhinotomy seen in 18% of our patients
and midfacial degloving seen in 9% of our patients. No association
were noted between the staging and type of surgical approach (p
value is 0.094).
As for the outcome, 64% of recurrence were noted amongst our
patients. No association were seen between staging of the disease
and recurrence (p value is 0.662) and type of surgery and recur-
rence (p value is 0.821). Among our patients, one patient under-
went radiotherapy and one patient underwent combined
radiotherapy and chemotherapy as there was intracranial involve-
ment. Radiotherapy regime for our patients were 30–50 centigray.
No major intraoperative or postoperative complications were
noted amongst our patients. Minor complication seen was oro-
antral fistula which healed itself. One our patient were noted to
have single-eye blindness as a result of tumour invasion into the
optic chiasm.4. Discussion
Hippocrates in the 5th century BCE mentioned on juvenile
nasopharyngeal angiofibroma in relation to nasal polyp.8 However,
its association with puberty was identified by Chelius in 1847 and
only in 1940 the term ‘angiofibroma’ was coined by Friedberg.2
Juvenile nasopharyngeal angiofibroma is an entity amongst
adolescence male.9 In our study, all patients were male with a
mean age upon presentation being 15 years which is similar to
other published study.10 Our patients mostly presented within
1–24 months with a mean of 12 months upon presentation. Com-
mon presenting symptoms include spontaneous painless epistaxis,
unilateral progressive nasal obstruction and nasal discharge.11
Albeit all our patients are Malay male, this data is not significant
as the local community around the University is resided by Malay
population.4 Radhowski mentioned that close to 70% of patients
are at Stage II upon presentation.12 This is similar to our patients
as mostly presented at Stage II upon diagnosis (46%).
Diagnosis of this entity was made based on history, physical
examination, nasoendoscopy and imaging mainly contrast-
enhanced computer tomography similar to most published jour-
nals.13 Computer tomography aids in staging the tumour upon
diagnosis, presence and extension of tumour upon follow-up.14,15
Apart from that, computer tomography enables surgeon to decide
on surgical approach for the patient. Biopsy was not done for any
of our patient as biopsy to obtain histological confirmation is not
practised in any centre. Most of our patients were at stage 2
(Fisch)7 upon diagnosis 46% with no association seen with the
duration of presentation.
Preoperative embolization is advocated prior to surgery in
many centres as it is postulated that occluding the responsible
artery from which the angiofibroma originates will reduce intraop-
erative blood loss16 and reduce the size of tumour which will facil-
itate resection. Naturally, an angiography is performed prior to
embolization to identify the source vessel.
In our centre, all our patients were subjected to preoperative
embolization prior to surgery. All embolizations were performed
in a single session with a pre-embolization angiogram performed
to analyse and determine extent of tumour blush, feeding arteries,
draining veins and extracranial to intracranial anastomosis. Pre-
operative embolization is done 24–72 h prior to surgical resection.
In our centre, materials used for embolization includes gelfoam,
polyvinyl alcohol foam and most recently, acrylic glue. Materialsd outcome of juvenile nasopharyngeal angiofibroma in a single centre: A
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foam and acrylic glue is more permanent. However, there are
authors who claims that preoperative embolization leads to incom-
plete tumour removal as it may obscure tumour borders17 leading
to residual which may further subject the patient to additional sur-
gery. Pre-operative embolization has been reported to have compli-
cations including risk of cerebrovascular accident, blindness
following ophthalmic artery embolization and also necrosis of skin
and soft tissue based on the compromised vascular supply. No com-
plications post-embolization was noted in our centre.
Surgery remains the first line treatment and is widely accepted
in most centres. Albeit the myriad surgical armamentarium that
exists till date, there is yet to be any consensus on the best choice
of surgery. Having said that, transmaxillary route is favoured by
many surgeons as it is said to have better exposure, lower morbid-
ity and no facial scar18 Similarly, all our patients were subjected to
surgery. Our patients were subjected to transnasal endoscopic
approach and a combined approach which comprises of two differ-
ent open approach to facilitate resection. It is also said that a more
extensive surgical resection has a better outcome and less recur-
rence. Recent advances however, have seen the rise in avant-
garde approach: transnasal endoscopy. It is now considered to be
a more plausible approach due to the avoidance of incisions, better
outcome and shorter duration of hospital stay.
As for the association between staging and type of surgery, no
significant association were demonstrated amongst our patients.
However, study by Bleir et al. reported a significant correlation
whereby endoscopic resection was opted for Andrew stage 1, 2,
3a.19 Several authors have stated that tumours at Stage IV ought
to undergo a combined intra- and extracranial approach.20
Recurrence is estimated to occur up to 46%21 within six months
postoperatively22 However, tumour extension into the sphenoid
sinus, pterygoid base and clivus is said to have a higher recurrence
rate. In our centre, the recurrence rate id 64% and it is postulated
that the possible cause among others includes patients delay in
surgical decision and inadequate embolization causing extensive
bleeding intraoperatively which leads to inadequate surgical resec-
tion. Staging at presentation has no association with recurrence in
our centre. Yet, study by Liu et al. showed a significant association
between staging and recurrence whereby higher recurrence were
observed with stage III and IV.16
Radiotherapy is an alternative treatment modality which was
initially considered only for unresectable tumours. Therapeutic
dose range is said to be between 30 and 46 Gy.23 Study by Reddy
et al. demonstrated that radiotherapy is just as effective as surgery
as a primary treatment modality with a 15% recurrence rate.24 In
our centre, only 2 patients were subjected to radiotherapy, both
patients with recurrence, one with intracranial extension and the
other refused surgery. Among notable complications following
radiotherapy includes arrest of craniofacial growth, temporal lobe
necrosis, cataracts, induction of future malignancies, hypopitu-
itarism and osteoradionecrosis. None of our patients demonstrated
serious complications following radiotherapy.
Chemotherapy has been said to be used as an alternative or an
adjunct when recurrence is seen following surgical treatment. In
our centre, only one patient with recurrence underwent combined
radiotherapy and chemotherapy.
Another treatment modality is hormonal therapy which is said
to reduce the size and vascularity of angiofibroma via antiandrogen
effect for instance flutamide, but is poorly tolerated due to its phys-
ical and psychological side-effects notably feminization effect.25
Apart from that, coblation, cryotherapy, electrocoagulation,
gamma-knife, harmonic scalpel, interstitial brachytherapy, KTP-
laser embolization and sclerotherapy are amongst other treatment
modalities which are used in other centres.Please cite this article in press as: Saniasiaya J., et al. Surgical management an
fifteen year experience. Egypt J Ear Nose Throat Allied Sci (2016), http://dx.doIn conclusion, based on our observation, surgery combined with
pre-operative embolization is the main modality of treatment in
our centres. However, inadequate embolization, patients delay
and refusal of surgery has led to a significant recurrent rate in
our centre. Hence, apart from timely diagnosis and management,
patient’s co-operative is prudent as to achieve a successful
outcome.
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